Phase I Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects with Actinic Keratosis. (2020). SKIN The Journal of Cutaneous Medicine, 4(6), s119. https://doi.org/10.25251/skin.4.supp.119